Luye Pharma Group Ltd (LUP) — Cash Flow Quality Index
Luye Pharma Group Ltd (LUP) has a Cash Flow Quality Index of 4.60x as of June 2023. Operating cash flow of €344.86 Million exceeds net income of €74.99 Million, indicating high earnings quality where cash backs reported profits. Explore LUP cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Luye Pharma Group Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Luye Pharma Group Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Luye Pharma Group Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Luye Pharma Group Ltd (2016–2025)
Year-by-year earnings quality comparison for Luye Pharma Group Ltd. For live market cap and the full company financial profile, see how much is Luye Pharma Group Ltd worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | €1.78 Billion | €618.75 Million | ▲ +710.6% |
| 2024 | 0.36x | €167.76 Million | €471.89 Million | ▼ -88.1% |
| 2023 | 3.00x | €1.60 Billion | €532.61 Million | ▲ +9.6% |
| 2022 | 2.73x | €1.65 Billion | €604.81 Million | ▲ +87.0% |
| 2020 | 1.46x | €1.03 Billion | €706.59 Million | ▲ +51.0% |
| 2019 | 0.97x | €1.42 Billion | €1.47 Billion | ▲ +20.8% |
| 2018 | 0.80x | €1.05 Billion | €1.30 Billion | ▼ -18.3% |
| 2017 | 0.98x | €964.10 Million | €981.37 Million | ▲ +47.9% |
| 2016 | 0.66x | €592.03 Million | €891.54 Million | — |